Chromogranin A (CHGA) Peptide
-
- Target See all Chromogranin A (CHGA) products
- Chromogranin A (CHGA)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DSLEAGLPLQ VRGYPEEKKE EEGSANRRPE DQELESLSAI EAELEKVAHQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHGA antibody,
Alternative Names: Chromogranin A control peptide, Chromogranin A antibody Blocking Peptide, Anti-Chromogranin A Blocking Peptide, CGA Blocking Peptide, Parathyroid Secretory Protein 1 Blocking Peptide, CHGA Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Chromogranin A (CHGA)
- Background
- CHGA is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocrine cells. Its gene product is a precursor to three biologically active peptides, vasostatin, pancreastatin, and parastatin. These peptides act as autocrine or paracrine negative modulators of the neuroendocrine system. Other peptides, including chromostatin, beta-granin, WE-14 and GE-25, are also derived from the full-length protein. However, biological activities for these molecules have not been shown.
- Molecular Weight
- 51 kDa
-